CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 159 enrolled
Drug / intervention
CGM initiation approachother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05928572
NCT05928572N/ACompleted

Effect of CGM Initiation Approach on Time In Range in People With Type 2 Diabetes

Holly Willis·interventional·Posted Jul 3, 2023·Updated Mar 4, 2026

In Brief

A clinical study evaluating CGM initiation approach for Type 2 Diabetes. Completed, enrolled 159 participants across 1 site.

Detailed Summary

This study includes two phases. The purpose of Phase 1 of this study is to understand if there is a difference between two ways of introducing a continuous glucose monitor (CGM) to people with type 2 diabetes (T2D). The study will evaluate the effect of using a nutrition-focused approach (NFA) versus a self-directed approach (SDA) during CGM initiation on time in range (TIR) glucose. TIR is the percent of time that someone's glucose is between 70 and 180 mg/dL. It is possible that the approach used to introduce the CGM could impact TIR and other outcomes. The purpose of Phase 2 of the study is to evaluate the impact of discontinuing CGM for 4 months after the completion of the Phase 1 study intervention on CGM-derived metrics, dietary intake assessment, and patient reported outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJul 3, 2023
Enrollment StartJul 25, 2023
Primary CompletionAug 16, 2024
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.0 years ago

Interventions

CGM initiation approachother

Use of a nutrition-focused approach versus a self-directed approach during CGM initiation